Generic Name and Formulations:
Psyllium hydrophilic mucilloid 3.4g; per rounded teaspoon; pwd.
- Naloxone Training Beneficial for PA Students
- Clinical and Research Applications of Screening and Assessment Questionnaires for Neuropathic Pain
- Intravenous Aminophylline Safe and Effective for Postdural Puncture Headache
Indications for KONSYL-D:
Adults and Children:
Mix in 8oz liq, then drink 8oz more liq. <6yrs: not recommended. 6–12yrs: ½ adult dose. ≥12yrs: 1 packet or rounded teaspoonful (1 rounded tablespoonful for Konsyl Orange) 1–3 times daily.
Signs/symptoms of appendicitis. Intestinal obstruction. Fecal impaction.
Rectal bleeding. Diabetes (sugar-containing forms).
Tablets block tetracycline absorption (give at least 1hr before or 2hrs after tetracycline).
Esophageal, gastric, enteral, rectal obstruction.
Original—10.6oz, 15.9oz; Original packets—30; D—11.5oz, 17.5oz; Orange—19oz; Sugar-Free—10.6oz, 15.9oz; Sugar-Free packets—30; Sugar-Free Orange—15oz; Easy Mix—8.8oz (w. scoop); Tabs—90; Caps—100
Clinical Pain Advisor Articles
- Risks Associated With Co-Administration of Aspirin and Other NSAIDs
- Stages of Low Back Pain Have Specific Sets of Clinical Indicators
- FDA Approves Aimovig for Migraine Prevention
- First Non-Opioid Drug Approved for Managing Opioid Withdrawal Symptoms
- Pain Interference Associated With Depression, Pain Self-Efficacy in Chronic Musculoskeletal Pain
- Effect of Prescription Drug Monitoring Programs on Fatal, Nonfatal Drug Overdoses
- Standardized SCS Workflow May Effectively Alleviate Failed Back Surgery Syndrome-Related Pain
- Marijuana Legalization and Opioid Prescribing Rates
- Medical Marijuana Users More Likely to Use Prescription Drugs for Medical, Nonmedical Purposes
- Interbrain Coupling During Handholding Associated With Analgesia, Empathy
- Remission Rates and Predictors of Chronic Headache
- Overuse and Underuse of Imaging Common in Low Back Pain Management
- Unit-Dose Packaging of Buprenorphine-Naloxone Effective on Unintentional Pediatric Exposure
- Language Used in Medical Record Can Affect Patient Care
- Opioid-Related Adverse Drug Events Associated With Worse Patient, Cost Outcomes